137 related articles for article (PubMed ID: 8676346)
1. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs.
Norman BH; Shih C; Toth JE; Ray JE; Dodge JA; Johnson DW; Rutherford PG; Schultz RM; Worzalla JF; Vlahos CJ
J Med Chem; 1996 Mar; 39(5):1106-11. PubMed ID: 8676346
[TBL] [Abstract][Full Text] [Related]
2. Effects of wortmannin analogs on bone in vitro and in vivo.
Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ
J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin.
Schultz RM; Merriman RL; Andis SL; Bonjouklian R; Grindey GB; Rutherford PG; Gallegos A; Massey K; Powis G
Anticancer Res; 1995; 15(4):1135-9. PubMed ID: 7653991
[TBL] [Abstract][Full Text] [Related]
4. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
Powis G; Bonjouklian R; Berggren MM; Gallegos A; Abraham R; Ashendel C; Zalkow L; Matter WF; Dodge J; Grindey G
Cancer Res; 1994 May; 54(9):2419-23. PubMed ID: 8162590
[TBL] [Abstract][Full Text] [Related]
5. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of fluorescent derivatives of wortmannin and demethoxyviridin as probes for phosphatidylinositol 3-kinase.
Giner JL; Kehbein KA; Cook JA; Smith MC; Vlahos CJ; Badwey JA
Bioorg Med Chem Lett; 2006 May; 16(9):2518-21. PubMed ID: 16464575
[TBL] [Abstract][Full Text] [Related]
7. The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage.
Price BD; Youmell MB
Cancer Res; 1996 Jan; 56(2):246-50. PubMed ID: 8542574
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of synthetic viridins derived from C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin.
Wipf P; Minion DJ; Halter RJ; Berggren MI; Ho CB; Chiang GG; Kirkpatrick L; Abraham R; Powis G
Org Biomol Chem; 2004 Jul; 2(13):1911-20. PubMed ID: 15227545
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase.
Creemer LC; Kirst HA; Vlahos CJ; Schultz RM
J Med Chem; 1996 Dec; 39(25):5021-4. PubMed ID: 8960564
[TBL] [Abstract][Full Text] [Related]
10. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells.
Tomiyama K; Nakata H; Sasa H; Arimura S; Nishio E; Watanabe Y
Biochem Biophys Res Commun; 1995 Jul; 212(1):263-9. PubMed ID: 7541986
[TBL] [Abstract][Full Text] [Related]
11. Pegylated wortmannin and 17-hydroxywortmannin conjugates as phosphoinositide 3-kinase inhibitors active in human tumor xenograft models.
Zhu T; Gu J; Yu K; Lucas J; Cai P; Tsao R; Gong Y; Li F; Chaudhary I; Desai P; Ruppen M; Fawzi M; Gibbons J; Ayral-Kaloustian S; Skotnicki J; Mansour T; Zask A
J Med Chem; 2006 Feb; 49(4):1373-8. PubMed ID: 16480272
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine.
Shah BH; Saeed SA
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):157-64. PubMed ID: 8556270
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy.
Zask A; Kaplan J; Toral-Barza L; Hollander I; Young M; Tischler M; Gaydos C; Cinque M; Lucas J; Yu K
J Med Chem; 2008 Mar; 51(5):1319-23. PubMed ID: 18269228
[TBL] [Abstract][Full Text] [Related]
14. Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70S6K activity.
Yao R; Cooper GM
Oncogene; 1996 Jul; 13(2):343-51. PubMed ID: 8710373
[TBL] [Abstract][Full Text] [Related]
15. Chemistry and biology of wortmannin.
Wipf P; Halter RJ
Org Biomol Chem; 2005 Jun; 3(11):2053-61. PubMed ID: 15917886
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylinositol-3'-kinase prevents induction of endotoxin tolerance in vitro.
Bowling WM; Flye MW; Qiu YY; Callery MP
J Surg Res; 1996 Jun; 63(1):287-92. PubMed ID: 8661212
[TBL] [Abstract][Full Text] [Related]
17. PI-3-kinase inhibitor Wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes.
Ridderstråle M; Tornqvist H
Biochem Biophys Res Commun; 1994 Aug; 203(1):306-10. PubMed ID: 8074671
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts.
Nakamura I; Sasaki T; Tanaka S; Takahashi N; Jimi E; Kurokawa T; Kita Y; Ihara S; Suda T; Fukui Y
J Cell Physiol; 1997 Aug; 172(2):230-9. PubMed ID: 9258344
[TBL] [Abstract][Full Text] [Related]
19. Involvement of stress-activated protein kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents.
Saleem A; Datta R; Yuan ZM; Kharbanda S; Kufe D
Cell Growth Differ; 1995 Dec; 6(12):1651-8. PubMed ID: 9019171
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor stimulation of phosphatidylinositol 3-kinase during wound closure in rabbit corneal epithelial cells.
Zhang Y; Akhtar RA
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1139-48. PubMed ID: 9152233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
